Moderna’s stock boosted by positive data from trial of melanoma treatment combined with Merck’s Keytruda
December 14, 2023 at 10:29 AM EST
Moderna's stock was on track for its biggest one-day gain in more than a year.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|